Dr. Curtis A. Pettaway, MD
- Medicare services, 2024
- 73
- Medicare patients, 2024
- 101
- Part D claims, 2024
- 97
- Publications
- 175
- Clinical trials
- 6
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Pettaway's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Curtis A. Pettaway is a urologist in Houston, Texas
Dr. Pettaway practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Pettaway's NPI, 1942306030, was assigned on September 15, 2006. Dr. Pettaway graduated from Lewis Katz School of Medicine in 1983. Dr. Pettaway holds Texas license G7096.
- NPI
- 1942306030NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8022203629
- NPI enumeration date
- September 15, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 69
- Medical school graduation
- 1983
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Curtis A. Pettaway practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Pettaway's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Curtis A. Pettaway is affiliated with 1 site of care and 1 medical group
Dr. Pettaway's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Curtis A. Pettaway's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pettaway practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Curtis A. Pettaway is one of 872 urologists in Texas
Urology is Dr. Pettaway's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Pettaway is board certified in urology by the American Board of Urology. Dmand AI has Dr. Pettaway's licenses on file in 10 states: Texas, Florida, Washington, Arizona, Georgia, Louisiana, Mississippi, Tennessee, Alabama and Oklahoma.
Specialties and state licenses
- Urology, TexasPrimary
- Florida license
- Washington license
- Arizona license
- Georgia license
- Louisiana license
- Mississippi license
- Tennessee license
- Alabama license
- Oklahoma license
Clinical focus
Dmand AI lists kidney stones, prostate surgery, urinary endoscopy and urinary tract infection among the conditions Dr. Pettaway treats.
Urologists near Dr. Pettaway
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Curtis A. Pettaway billed Medicare for 73 services in 2024
CMS data shows 73 Medicare services from Dr. Pettaway across 2 procedure codes in 2024, all of them office visits, for 101 Medicare patients. Medicare paid $9,843 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Pettaway's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 662024: 7311%
- Surgery
- 2023: 302024: 0100%
Dr. Pettaway compared with the Texas median for urologists, 2024
- Dr. Pettaway
- Texas median
- Medicare services
- 73vs 1,57095% below
- Medicare patients
- 101vs 40075% below
- Part D claims
- 31vs 91897% below
Medians across 809 urologists in Texas with Dmand AI profiles that report each measure.
Dr. Pettaway's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Pettaway?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pettaway and other urologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Curtis A. Pettaway treated 101 Medicare patients in 2024, average age 72
CMS counts 101 Medicare patients who saw Dr. Pettaway in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Pettaway's median patient age at 73, with 7% women.
Dr. Pettaway's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Pettaway's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure69%
- Ischemic heart disease44%
- Arthritis38%
- Diabetes38%
- Anxiety28%
- Chronic kidney disease27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Pettaway's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women7%
- Men93%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Curtis A. Pettaway wrote 97 Medicare Part D claims in 2024
In 2024, Dr. Pettaway wrote 97 Medicare Part D claims for 48 patients. 85% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $169 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.
Dr. Pettaway's Part D claims by kind of drug, 2024
- Generic82 claims85%
- Brand-name15 claims15%
Dr. Pettaway's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Pettaway's Part D claims, 2024
- Opioids12%12 of 97 claims
- Antibiotics36%35 of 97 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 322024: 313%
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Curtis A. Pettaway scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Pettaway for performance year 2024, reported as part of a group. Dr. Pettaway accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pettaway as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Pettaway's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)
Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Curtis A. Pettaway has 175 publications on record
Dmand AI links 175 papers to Dr. Pettaway, published from 2005 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Prostatic Neoplasms, Penile Neoplasms and Black or African American. Dr. Pettaway has published most often in J Urol. Dr. Pettaway's most frequent co-authors are Philippe E. Spiess, MD, Christopher J. Logothetis, MD and John W. Davis, MD.
Dr. Pettaway's papers by year, 2016 to 2025
Topics Dr. Pettaway writes about most
- Prostatic Neoplasms
- Penile Neoplasms
- Black or African American
- Carcinoma, Squamous Cell
- Prostate-Specific Antigen
- Prostatectomy
- Lymphatic Metastasis
- Lymph Node Excision
Dr. Pettaway's most frequent co-authors
- Philippe E. Spiess, MD32 shared papers
- Christopher J. Logothetis, MD18 shared papers
- John W. Davis, MD15 shared papers
Recent publications by Dr. Pettaway
J Natl Compr Canc Netw
Urol Clin North Am
See who Dr. Pettaway researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pettaway works with, so you can find a warm path to the right urologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Curtis A. Pettaway has worked on 6 clinical trials
Dmand AI links Dr. Pettaway to 6 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Penile Neoplasms, Prostatic Neoplasms and Penile Diseases. M.D. Anderson Cancer Center sponsors the most, 3.
Clinical trials with Dr. Pettaway by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Pettaway's trials
- Penile Neoplasms
- Prostatic Neoplasms
- Penile Diseases
- Prostatic Diseases
Investigators on the most trials with Dr. Pettaway
Recent clinical trials with Dr. Pettaway
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma (opens in a new tab)
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Curtis A. Pettaway received $2,914 in industry payments from 2016 to 2024
CMS Open Payments shows 12 general payments to Dr. Pettaway from 6 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 69% of the total. Progenics Pharmaceuticals, Inc. paid the most, $2,190.
General payments to Dr. Pettaway by program year, 2016 to 2024
General payments to Dr. Pettaway by kind, 2016 to 2024
- Speaker and faculty fees$2,00069%
- Food and beverage$83429%
- Education$803%
Companies that paid Dr. Pettaway the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Curtis A. Pettaway has 1 award and honors on record
Dmand AI lists 1 award for Dr. Pettaway, most recently Top Doctors:SE Texas in 2013.
Awards and honors for Dr. Pettaway
- 2013
- Top Doctors:SE Texas
Source: Dmand AI Professional Profile Data
Dr. Curtis A. Pettaway graduated from Lewis Katz School of Medicine
Dr. Pettaway graduated from Lewis Katz School of Medicine in 1983.
- Medical school
- Board certified in urology
Source: Dmand AI Professional Profile Data
Dr. Curtis A. Pettaway accepts plans from 14 insurance carriers
Dr. Pettaway is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Alliant Health Plans
- Elevance
- HCSC
- Baylor Scott and White
- Blue Cross and Blue Shield of Kansas City
- +6 more carriersWith a free account
Plan types Dr. Pettaway accepts, by number of carriers
- HMO9
- PPO8
- POS4
- Medicare3
- EPO2
Source: Dmand AI Insurance Network Data
Sources for Dr. Curtis A. Pettaway's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Curtis A. Pettaway
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Curtis A. Pettaway's NPI number?
Dr. Curtis A. Pettaway's NPI number is 1942306030. It was assigned on September 15, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Curtis A. Pettaway?
Dr. Curtis A. Pettaway is a urologist in Houston, Texas. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Where does Dr. Curtis A. Pettaway practice?
Dr. Pettaway practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Pettaway's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Curtis A. Pettaway's medical license number?
Dr. Pettaway holds Texas license G7096, one of the licenses on file in 10 states.
Which states has Dr. Curtis A. Pettaway been licensed in?
Dmand AI has state licenses on file for Dr. Pettaway in Texas (1984 to 2026), Florida (since 2021), Washington (2024 to 2027), Arizona (2024 to 2026), Georgia (2024 to 2026), Louisiana (2024 to 2026), Mississippi (2024 to 2026), Tennessee (2024 to 2026), Alabama (2024 to 2025) and Oklahoma (2020 to 2025).
Which hospitals is Dr. Curtis A. Pettaway affiliated with?
Dr. Pettaway practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. Curtis A. Pettaway part of?
Dr. Pettaway is linked to Physicians Referral Service.
Does Dr. Curtis A. Pettaway accept Medicare?
Yes. CMS data shows Dr. Pettaway billed Medicare for 73 services in 2024, and Dr. Pettaway accepts Medicare assignment.
Does Dr. Curtis A. Pettaway offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Pettaway as offering telehealth services.
What is Dr. Curtis A. Pettaway's MIPS score?
Dr. Pettaway's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Curtis A. Pettaway see?
CMS counts 101 Medicare patients who saw Dr. Pettaway in 2024, with an average age of 72.
Is Dr. Curtis A. Pettaway board certified?
Yes. Dr. Pettaway is board certified in urology by the American Board of Urology.
What services does Dr. Curtis A. Pettaway bill to Medicare?
In 2024, Dr. Pettaway's most billed Medicare services were office visit, new patient (99205) and office visit, new patient (99204).
Where did Dr. Curtis A. Pettaway go to medical school?
Dr. Pettaway graduated from Lewis Katz School of Medicine in 1983.
What drugs does Dr. Curtis A. Pettaway prescribe most?
In 2024 Medicare Part D data, Dr. Pettaway's most prescribed drugs by claims were Tamsulosin HCl and Sulfamethoxazole-Trimethoprim.
Has Dr. Curtis A. Pettaway received payments from drug or device companies?
CMS Open Payments shows $2,914 in general payments to Dr. Pettaway from 6 companies from 2016 to 2024. The largest total came from Progenics Pharmaceuticals, Inc.
How long has Dr. Curtis A. Pettaway been practicing?
Dr. Pettaway graduated from medical school in 1983, 43 years ago.
Does Dr. Curtis A. Pettaway do research?
Dmand AI links 175 publications to Dr. Pettaway, published from 2005 to 2025. Dr. Pettaway has worked on 6 clinical trials.
Who does Dr. Curtis A. Pettaway publish with?
Dr. Pettaway's most frequent co-authors are Philippe E. Spiess, MD (32 shared papers), Christopher J. Logothetis, MD (18 shared papers) and John W. Davis, MD (15 shared papers).
What insurance does Dr. Curtis A. Pettaway accept?
Dr. Pettaway is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to urology practices?
See urologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card